Would a third class of drugs help move move medicines from Rx to OTC?
No, not necessarily. Existing law and regulation provide sufficient flexibility for companies to work with FDA to explore new or different approaches to moving prescription medicines to nonprescription status. Recent examples in which an application sponsor has voluntarily committed to innovative distribution, information support, or educational mechanisms include the emergency contraceptive levonorgestrel, orlistat to help in weight loss, and nicotine replacement therapies to help stop smoking.